Mitigation of magnetic particle hyperthermia side effects by magnetic field controls

Reference

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
   PubMed Web of Science ®Google Scholar
• Makridis A, Topouridou K, Tziomaki M, et al. In vitro application of Mn-ferrite nanoparticles as novel magnetic hyperthermia agents. J Mater Chem B. 2014;2:8390–8398.
   PubMed Web of Science ®Google Scholar
• Dutz S, Hergt R. Magnetic particle hyperthermia-a promising tumour therapy? Nanotechnology. 2014;25:452001.
   PubMed Web of Science ®Google Scholar
• Singh A, Jain S, Sahoo SK. Magnetic nanoparticles for amalgamation of magnetic hyperthermia and chemotherapy: an approach towards enhanced attenuation of tumor. Mater Sci Eng C. 2020;110:110695.
   PubMed Web of Science ®Google Scholar
• Wankhede M, Bouras A, Kaluzova M, et al. Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy. Expert Rev Clin Pharmacol. 2012;5:173–186.
   PubMed Web of Science ®Google Scholar
• Chang D, Lim M, Goos JA, et al. Biologically targeted magnetic hyperthermia: potential and limitations. Front. Pharmac. 2018;9:831.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7–30.
   PubMed Web of Science ®Google Scholar
• Maier-Hauff K, Ulrich F, Nestler D, et al. Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J Neurooncol. 2011;103:317–324.
   PubMed Web of Science ®Google Scholar
• Gupta R, Sharma D. Evolution of magnetic hyperthermia for glioblastoma multiforme therapy. ACS Chem Neurosci. 2019;10:1157–1172.
   PubMed Web of Science ®Google Scholar
• Bauer LM, Situ SF, Griswold MA, et al. High-performance iron oxide nanoparticles for magnetic particle imaging – guided hyperthermia (hMPI). ). Nanoscale. 2016;8:12162–12169.
   PubMed Web of Science ®Google Scholar
• Angelakeris M. Magnetic Particle hyperthermia. In: Sattler KD, editor. 21st century nanoscience handbook. Boca Raton (FL): CRC Press; 2020.
   Google Scholar
• Perigo EA, Hemery G, Sandre O, et al. Fundamentals and advances in magnetic hyperthermia. Appl. Phys. Rev. 2015;2:041302.
   Web of Science ®Google Scholar
• Shetake NG, Balla MM, Kumar A, et al. Magnetic hyperthermia therapy: an emerging modality of cancer treatment in combination with radiotherapy. J Radiat Cancer Res. 2016;7:13–17.
   Google Scholar
• Rosensweig RE. Heating magnetic fluid with alternating magnetic field. J Magn. Magn. Mater. 2002; 252:370–374.
   Web of Science ®Google Scholar
• Johannsen M, Thiesen B, Wust P, et al. Magnetic nanoparticle hyperthermia for prostate cancer. Int J Hyperthermia. 2010;26:790–795.
   PubMed Web of Science ®Google Scholar
• Johannsen M, Gneveckow U, Taymoorian K, et al. Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: results of a prospective phase I trial. Int J Hyperthermia. 2007;23:315–323.
   PubMed Web of Science ®Google Scholar
• Wust P, Gneveckow U, Johannsen M, et al. Magnetic nanoparticles for interstitial thermotherapy-feasibility, tolerance and achieved temperatures. Int J Hyperthermia. 2006;22:673–685.
   PubMed Web of Science ®Google Scholar
• Mahmoudi K, Bouras A, Bozec D, et al. Magnetic hyperthermia therapy for the treatment of glioblastoma: a review of the therapy’s history, efficacy and application in humans. Int J Hyperthermia. 2018;34:1316–1328.
   PubMed Web of Science ®Google Scholar
• Southern P, Pankhurst QA. Commentary on the clinical and preclinical dosage limits of interstitially administered magnetic fluids for therapeutic hyperthermia based on current practice and efficacy models. Int J Hyperthermia. 2018;34:671–686.
   PubMed Web of Science ®Google Scholar
• Schier P, Barton C, Spassov S, et al. European research on magnetic nanoparticles for biomedical applications: standardisation aspects. In: Korbicz J, Maniewski R, Patan K, et al., editors. Polish Conference on Biocybernetics and Biomedical Engineering. Vol. 1033. Cham (Switzerland): Springer. 2019. p. 316–326.
   Google Scholar
• Brezovich IA. Low frequency hyperthermia: capacitive and ferromagnetic thermoseed methods. Med Phys Monograph. 1988; 16:82–111.
   Google Scholar
• Angelakeris M. Magnetic nanoparticles: a multifunctional vehicle for modern theranostics. Biochim Biophys Acta Gen Subj. 2017;1861:1642–1651.
   PubMed Web of Science ®Google Scholar
• Hergt R, Dutz S, Röder M. Effects of size distribution on hysteresis losses of magnetic nanoparticles for hyperthermia. J Phys Condens Matter. 2008;20:385214.
   PubMed Web of Science ®Google Scholar
• Bellizzi G, Bucci OM. On the optimal choice of the exposure conditions and the nanoparticle features in magnetic nanoparticle hyperthermia. Int J Hyperthermia. 2010;26:389–403.
   PubMed Web of Science ®Google Scholar
• Bellizzi G, Bucci OM, Chirico G. Numerical assessment of a criterion for the optimal choice of the operative conditions in magnetic nanoparticle hyperthermia on a realistic model of the human head. Int J Hyperthermia. 2016;32:688–703.
   PubMed Web of Science ®Google Scholar
• Stigliano RV, Shubitidze F, Petryk JD, et al. Mitigation of eddy current heating during magnetic nanoparticle hyperthermia therapy. Int J Hyperthermia. 2016;32:735–748.
   PubMed Web of Science ®Google Scholar
• Herrera LJM, Bruvera IJ, Scaffardi LB, et al. Sizing and Eddy currents in magnetic core nanoparticles: an optical extinction approach. Phys Chem Chem Phys. 2017;19:3076–3083.
   PubMed Web of Science ®Google Scholar
• Ivkov R, DeNardo SJ, Daum W, et al. Application of high amplitude alternating magnetic fields for heat induction of nanoparticles localized in cancer. Clin Cancer Res. 2005;11:7093s–7103s.
   PubMed Web of Science ®Google Scholar
• Attaluri A, Kandala SK, Zhou H, et al. Magnetic nanoparticle hyperthermia for treating locally advanced unresectable and borderline resectable pancreatic cancers: the role of tumor size and eddy-current heating. Int J Hyperthermia. 2020;37:108–119.
   PubMed Web of Science ®Google Scholar
• Nieskoski MD, Trembly BS. Comparison of a single optimized coil and a Helmholtz pair for magnetic nanoparticle hyperthermia. IEEE Trans Biomed Eng. 2014;61:1642–1650.
   PubMed Web of Science ®Google Scholar
• Lerch IA, Kohn S. Radiofrequency hyperthermia: the design of coil transducers for local heating. Int J Radiat Oncol Biol Phys. 1983;9:939–948.
   PubMed Web of Science ®Google Scholar
• Gneveckow U, Jordan A, Scholz R, et al. Description and characterization of the novel hyperthermia and thermoablation- system for clinical magnetic fluid hyperthermia. Med Phys. 2004;31:1444–1451.
   PubMed Web of Science ®Google Scholar
• Kumar A, Attaluri A, Mallipudi R, et al. Method to reduce non-specific tissue heating of small animals in solenoid coils. Int J Hyperthermia. 2013;29:106–120.
   PubMed Web of Science ®Google Scholar
• Simeonidis K, Liébana-Viñas S, Wiedwald U, et al. A versatile large-scale and green process for synthesizing magnetic nanoparticles with tunable magnetic hyperthermia features. RSC Adv. 2016;6:53107–53117.
   Web of Science ®Google Scholar
• Salloum M, Ma RH, Weeks D, et al. Controlling nanoparticle delivery in magnetic nanoparticle hyperthermia for cancer treatment: experimental study in agarose gel. Int J Hyperthermia. 2008;24:337–345.
   PubMed Web of Science ®Google Scholar
• Chen ZJ, Broaddus WC, Viswanathan RR, et al. Intraparenchymal drug delivery via positive-pressure infusion: experimental and modeling studies of poroelasticity in brain phantom gels. IEEE Trans Biomed Eng. 2002;49:85–96.
   PubMed Web of Science ®Google Scholar
• Makridis A, Curto S, Van Rhoon GC, et al. A standardisation protocol for accurate evaluation of specific loss power in magnetic hyperthermia. J Phys D Appl Phys. 2019;52:255001.
   Web of Science ®Google Scholar
• Neufeld E, Fuetterer M, Murbach M, et al. Rapid method for thermal dose-based safety supervision during MR scans. Bioelectromagnetics. 2015;36:398–407.
   PubMed Web of Science ®Google Scholar
• Bordelon DE, Cornejo C, Grüttner C, et al. Magnetic nanoparticle heating efficiency reveals magneto-structural differences when characterized with wide ranging and high amplitude alternating magnetic fields. J Appl. Phys. 2011;109:124904.
   Web of Science ®Google Scholar
• Rodrigues HF, Mello FM, Branquinho LC, et al. Real-time infrared thermography detection of magnetic nanoparticle hyperthermia in a murine model under a non-uniform field configuration. Int J Hyperthermia. 2013;29:752–767.
   PubMed Web of Science ®Google Scholar
• Dabbagh A, Hedayatnasab Z, Karimian H, et al. Polyethylene glycol-coated porous magnetic nanoparticles for targeted delivery of chemotherapeutics under magnetic hyperthermia condition. Int J Hyperthermia. 2019;36:104–114.
   PubMed Web of Science ®Google Scholar
• Sumser K, Neufeld E, Verhaart RF, et al. Feasibility and relevance of discrete vasculature modeling in routine hyperthermia treatment planning. Int J Hyperthermia. 2019;36:800–810.
   Web of Science ®Google Scholar
• Sebeke L, Deenen DA, Maljaars E, et al. Model predictive control for MR-HIFU-mediated, uniform hyperthermia. Int J Hyperthermia. 2019;36:1039–1049.
   Web of Science ®Google Scholar
• Maniotis N, Myrovali E, Kalpaxidou Z, et al. Ex-vivo evaluation of magnetite magnetic nanoparticles as magnetic hyperthermia carriers. Proceedings of the 1st EMF-Med World Conference on Biomedical Applications of Electromagnetic Fields and COST EMF-MED, Final Event with 6th MCM. 2018. p. 1–2.
   Google Scholar
• Harabech M, Kiselovs NR, Maenhoudt W, et al. Experimental ex-vivo validation of PMMA-based bone cements loaded with magnetic nanoparticles enabling hyperthermia of metastatic bone tumors. AIP Adv. 2017;7:056704.
   Web of Science ®Google Scholar
• Efremova MV, Nalench YA, Myrovali E, et al. Size-selected Fe3O4-Au hybrid nanoparticles for improved magnetism-based theranostics. Beilstein J Nanotechnol. 2018;9:2684–2699.
   PubMed Web of Science ®Google Scholar